Physicians should consider integrating GLP-1 agonists and CPAP therapy in patients with obesity and OSA, supported by early diagnosis and adherence strategies, to maximize clinical outcomes
Personalized GLP-1 plans guided by licensed clinicians Built-in follow-up care that adapts with your progress Treatment recommendations matched to your goals Proactive support around side effects and expectations One private place for messaging, tracking, and refills Discreet shipping with a cleaner online care journey Generic fixed plans that rarely change over time Little education or long-term care structure Basic intake followed by more fragmented steps Side effects handled more reactively than proactively Limited support after the prescription is written More friction, less clarity, and weaker continuity Kala lost 40 lbs Morgan lost 36 lbs Christopher lost 42 lbs Noelle lost 29 lbs 8 out of 10 members lose 14+ lbs in 90 days* Join members nationwide moving through onboarding, treatment, check-ins, and refill care with less friction and better visibility
Saw palmetto extract only, often without standardized support nutrients.*
J Clin Pharmacol 2011
As a customer, you can concentrate on creating your masterpiece while CDMOs like Bachem handle the rest
Part 2 will demonstrate that treatment with semaglutide 2.4 mg in adults with MASH and moderate to advanced liver fibrosis reduces the risk of liver-related clinical events compared to placebo after 240 weeks
